Cargando…
Serum Lipidomics Profiling to Identify Biomarkers for Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the leading cause of cancer death worldwide, which ranks top in both incidence and mortality. To broaden our understanding of the lipid metabolic alterations in NSCLC and to identify potential biomarkers for early diagnosis, we performed nontargeted lipidomics a...
Autores principales: | Chen, Yingrong, Ma, Zhihong, Shen, Xiongrong, Li, Liqin, Zhong, Jing, Min, Li Shan, Xu, Limin, Li, Hongwei, Zhang, Jianbin, Dai, Licheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106807/ https://www.ncbi.nlm.nih.gov/pubmed/30175133 http://dx.doi.org/10.1155/2018/5276240 |
Ejemplares similares
-
Simultaneous quantification of serum monounsaturated and polyunsaturated phosphatidylcholines as potential biomarkers for diagnosing non-small cell lung cancer
por: Chen, Yingrong, et al.
Publicado: (2018) -
Biomarker Identification and Pathway Analysis by Serum Metabolomics of Lung Cancer
por: Chen, Yingrong, et al.
Publicado: (2015) -
Serum Lipidomic Profiling in Breast Cancer to Identify Screening, Diagnostic, and Prognostic Biomarkers
por: Fichtali, Karima, et al.
Publicado: (2020) -
Serum metabolomic and lipidomic profiling identifies diagnostic biomarkers for seropositive and seronegative rheumatoid arthritis patients
por: Luan, Hemi, et al.
Publicado: (2021) -
Lipidomics Profiles and Lipid Metabolite Biomarkers in Serum of Coal Workers’ Pneumoconiosis
por: Chen, Zhangjian, et al.
Publicado: (2022)